8-KLeadership ChangesRegulation FD

Elevance Health, Inc. 8-K Report, Executive Changes (Feb 8, 2012)

Filed February 8, 2012For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on February 8, 2012, primarily to announce the departure of Brian A. Sassi, Executive Vice President, Marketing and President & CEO, Consumer Business Unit. Mr. Sassi was terminated without cause and will remain with the company until early March 2012 to assist with the transition of his duties. This management change, while notable, appears to be an isolated event and the company has provided a statement regarding its implications. In addition to the executive departure, WellPoint also reaffirmed its full-year 2012 earnings per share (EPS) guidance of at least $7.60. This guidance is expected to be communicated to securities analysts and investors during meetings scheduled from February 8 to February 23, 2012. The company also included a standard safe harbor statement for forward-looking information, highlighting various risks and uncertainties that could affect future performance, including those related to healthcare reform, market trends, and regulatory environments.

Key Highlights

  • 1Termination of Brian A. Sassi, EVP, Marketing & President & CEO, Consumer Business Unit, without cause.
  • 2Mr. Sassi to remain employed through early March 2012 to facilitate a smooth transition.
  • 3Reaffirmation of full-year 2012 EPS guidance of at least $7.60 per share.
  • 4Guidance to be discussed with securities analysts and investors between February 8 and February 23, 2012.
  • 5Inclusion of a standard safe harbor statement for forward-looking information.
  • 6Disclosure of various risks and uncertainties that could impact future financial results.

Frequently Asked Questions

The primary reason for this 8-K filing is to report the termination of Brian A. Sassi, an Executive Vice President and key business unit leader, without cause. The company also used this filing to reaffirm its financial guidance for the full year 2012.

WellPoint reaffirmed its earnings per share guidance for the full year 2012 to be at least $7.60 per share.

The company provided a safe harbor statement indicating that its forward-looking statements are subject to various risks and uncertainties. These include regulatory changes (such as the Affordable Care Act), healthcare cost trends, competition, enrollment fluctuations, government program risks (Medicare/Medicaid), potential rating downgrades, litigation, information system failures, and general economic conditions.

The filing states that Mr. Sassi was terminated 'without cause' and will remain to assist with the transition. While the departure of a senior executive is always noted, the company's reaffirmation of its 2012 EPS guidance suggests that, at the time of this filing, they did not anticipate a material negative impact on their financial outlook stemming directly from this event.